Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial.

Ribrag, Vincent

Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial. [electronic resource] - Lancet (London, England) Jun 2016 - 2402-11 p. digital

Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1474-547X

10.1016/S0140-6736(15)01317-3 doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Biomarkers, Tumor--analysis
Bone Marrow Neoplasms--drug therapy
Burkitt Lymphoma--chemistry
Central Nervous System Neoplasms--drug therapy
Cyclophosphamide--administration & dosage
Cytarabine--administration & dosage
Doxorubicin--administration & dosage
Drug Administration Schedule
Female
France
Humans
Hydrocortisone--administration & dosage
Injections, Intravenous
Male
Methotrexate--administration & dosage
Methylprednisolone--administration & dosage
Middle Aged
Neoplasm Staging
Odds Ratio
Patient Selection
Prednisone--administration & dosage
Proportional Hazards Models
Rituximab--administration & dosage
Treatment Outcome
Vincristine--administration & dosage